Nā mea hana a me nā mea hoʻolako - hale hana huahana Kina

Lasofoxifene Tartrate CAS 190791-29-8 Maʻemaʻe Chiral ≥99.0% Maʻemaʻe ≥98.0% (HPLC) API Maʻemaʻe Kiʻekiʻe

Inoa Kemika: Lasofoxifene Tartrate

CAS: 190791-29-8

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe Chiral: ≥99.0%Maʻemaʻe: ≥98.0% (HPLC)

I ka mālama ʻana i ka Postmenopausal Osteoporosis

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Hale Hana Kiʻekiʻe

Inoa Kemika: Imatinib Mesylate (ʻano alpha)

CAS: 220127-57-1

ʻAno: Keʻokeʻo a i ʻole-White Crystalline Powder

ʻIke HPLC: 98.0%~102.0%

ʻO Imatinib Mesylate i ka mālama ʻana o Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate Maʻemaʻe Kiʻekiʻe

Inoa: N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea

Synonyms: Imatinib Mesylate Intermediate

CAS: 152460-10-1

ʻAno: ʻĀlani ʻAlani a i ka pauda melemele a i ke aniani

Maʻemaʻe: ≥98.0% (HPLC)

ʻO Intermediate o Imatinib Mesylate (CAS: 220127-57-1) i ka mālama ʻana iā Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
4-[(4-Methylpiperazin-1-yl)methyl]ʻakika benzoic dihydrochloride CAS 106261-49-8 Imatinib Mesylate Waena Maʻemaʻe Kiʻekiʻe

4-[(4-Methylpiperazin-1-yl)methyl]ʻakika benzoic Dihydrochloride

CAS: 106261-49-8

ʻAno: Keʻokeʻo a kokoke i ka pauka keʻokeʻo i ke aniani

Maʻemaʻe: ≥98.0% (HPLC)

ʻO Intermediate o Imatinib Mesylate (CAS: 220127-57-1) i ka mālama ʻana iā Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate Maʻemaʻe Kiʻekiʻe

N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine

CAS: 152460-09-8

Nānā: Melemele a ʻaneʻane Melemele Pada

Maʻemaʻe: ≥98.0% (HPLC)

ʻO Intermediate o Imatinib Mesylate (CAS: 220127-57-1) i ka mālama ʻana iā Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Maʻemaʻe ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Inoa Kemika: 3,6-Dichloropyrazine-2-Carbonitrile

CAS: 356783-16-9

ʻAno: Melemele ʻeleʻele a i ka pauka keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

Intermediate o Favipiravir (CAS: 259793-96-9) i ka mālama ʻana i nā maʻi me COVID-19 i ʻōlelo ʻia e WHO

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Maʻemaʻe ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Inoa Kemika: 3,6-Difluoropyrazine-2-Carbonitrile

CAS: 356783-28-3

ʻAno: Melemele ʻeleʻele a i ka pauka keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

Intermediate o Favipiravir (CAS 259793-96-9) i ka mālama ʻana i nā maʻi maʻi maʻi influenza a me COVID-19

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Maʻemaʻe ≥99.0% Favipiravir Intermediate COVID-19

Inoa Kemika: Diethyl Aminomalonate Hydrochloride

CAS: 13433-00-6

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

Maʻemaʻe: ≥99.0%

Intermediate o Favipiravir (CAS: 259793-96-9) i ka mālama ʻana i nā maʻi me COVID-19 i ʻōlelo ʻia e WHO

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
2-Aminopropanediamide CAS 62009-47-6 Favipiravir Intermediate COVID-19 Maʻemaʻe Kiʻekiʻe

Inoa Kemika: 2-Aminopropanediamide

CAS: 62009-47-6

Ke 'ano: Pada Melemele Malamalama

Maʻemaʻe: ≥98.0% (LCMS-ELSD)

Intermediate o Favipiravir (CAS: 259793-96-9) i ka mālama ʻana i nā maʻi me COVID-19 i ʻōlelo ʻia e WHO

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
Favipiravir CAS 259793-96-9 T-705 Maʻemaʻe ≥99.0% (HPLC) COVID-19 API Hale Kūlana Kiʻekiʻe

Inoa Kemika: Favipiravir;T-705

CAS: 259793-96-9

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

I ka mālama ʻana i nā maʻi maʻi influenza a me COVID-19

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
ʻO Cetrorelix Acetate CAS 130143-01-0 GnRH Antagonist Peptide Purity (HPLC) ≥98.0% High Quality

Inoa Kemika: Cetrorelix Acetate

CAS: 130143-01-0

Nānā: Pada Keʻokeʻo

Maʻemaʻe Peptide (HPLC): ≥98.0%

ʻO ka mea kū'ē kū'ē o GnRH Receptor

GMP Peptides, API, Mea Kiʻekiʻe

Hoʻokaʻaʻike: Kauka Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ninau kikoʻī
Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Inoa Kemika: Deslorelin Acetate

CAS: 57773-65-6

ʻAno: ʻO ka pauka keʻokeʻo a i ʻole ka pauda keʻokeʻo kokoke

Maʻemaʻe Peptide (HPLC): ≥98.0% (Ma ka hoʻohui ʻāina)

Maʻiʻo Peptide (N%): ≥80.0%

ʻIke: 95.0%~105.0% (Ma ka Anhydrous, Acetic Acid-free)

GnRH Agonist

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
Octreotide Acetate CAS 83150-76-9 Peptide Maʻemaʻe (HPLC) ≥98.0% API Kūlana Kiʻekiʻe

Inoa Kemika: Octreotide Acetate

CAS: 83150-76-9

Nānā: Pada Keʻokeʻo

Maʻemaʻe Peptide (Na HPLC): ≥98.0%

ʻIke: 95%~105%

ʻO Acromegaly a me Gastroenteropancreatic Tumor

Hoʻokaʻaʻike: Kauka Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ninau kikoʻī
ʻO Sodium Valproate (VPA) CAS 1069-66-5 API Hale Hana Maʻemaʻe Kiʻekiʻe

Inoa Kemika: Sodium Valproate (VPA)

Synonyms: Valproic Acid Sodium Salt

CAS: 1069-66-5

ʻAno: Keʻokeʻo a ʻaneʻane keʻokeʻo Crystalline Powder, Hygroscopic

ʻIke: 98.5%~101.0% (Titration)

ʻO kahi lāʻau anti-epileptic ākea ākea e hoʻomanawanui maikaʻi

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

Inquiry: alvin@ruifuchem.com

ninau kikoʻī

<< < Mamua 324 325 326 327 328 329 330 Aʻe >>> ʻAoʻao 327 / 341

Nā huahana

Tetrabutylammonium Fluoride Trihydrate CAS 87749-50-6 Maʻemaʻe >99.0% (Titration)

Tetrabutylammonium Bromide (TBAB) CAS 1643-19-2 Maʻemaʻe >99.0% ((Titration)

Ammonium Bromide CAS 12124-97-9 Maʻemaʻe >99.0% (Titration)

Tetra-n-Octylammonium Bromide (TOAB) CAS 14866-33-2 Maʻemaʻe >98.0% (Titration)

Didodecyldimethylammonium Bromide CAS 3282-73-3 Maʻemaʻe >99.0% (GC)

(S)-(-)-TolBINAP CAS 100165-88-6 Maʻemaʻe >98.0% (HPLC)

Dibromobis(triphenylphosphine)nickel(II) CAS 14126-37-5 Maʻemaʻe >99.0% (GC)

tert-Amyl Alcohol CAS 75-85-4 Maʻemaʻe >99.5% (GC)

tert-Butyl Hydroperoxide (TBHP) (70% i ka wai) CAS 75-91-2

Sodium tert-Butoxide CAS 865-48-5 Maʻemaʻe >99.0% (T)

Lithium tert-Butoxide CAS 1907-33-1 Maʻemaʻe >99.0% (Titration)

Trimethyltetradecylammonium Chloride CAS 4574-04-3 Maʻemaʻe >99.0% (T)

Tributyltin Hydride CAS 688-73-3 Maʻemaʻe >97.0% (GC) Loaʻa iā 0.05% BHT ma ke ʻano he Stabilizer

Lasofoxifene Tartrate CAS 190791-29-8 Maʻemaʻe Chiral ≥99.0% Maʻemaʻe ≥98.0% (HPLC) API Maʻemaʻe Kiʻekiʻe

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Hale Hana Kiʻekiʻe

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate Maʻemaʻe Kiʻekiʻe

4-[(4-Methylpiperazin-1-yl)methyl]ʻakika benzoic dihydrochloride CAS 106261-49-8 Imatinib Mesylate Waena Maʻemaʻe Kiʻekiʻe

N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate Maʻemaʻe Kiʻekiʻe

3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Maʻemaʻe ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Maʻemaʻe ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Maʻemaʻe ≥99.0% Favipiravir Intermediate COVID-19

2-Aminopropanediamide CAS 62009-47-6 Favipiravir Intermediate COVID-19 Maʻemaʻe Kiʻekiʻe

Favipiravir CAS 259793-96-9 T-705 Maʻemaʻe ≥99.0% (HPLC) COVID-19 API Hale Kūlana Kiʻekiʻe

ʻO Cetrorelix Acetate CAS 130143-01-0 GnRH Antagonist Peptide Purity (HPLC) ≥98.0% High Quality

Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Octreotide Acetate CAS 83150-76-9 Peptide Maʻemaʻe (HPLC) ≥98.0% API Kūlana Kiʻekiʻe

ʻO Sodium Valproate (VPA) CAS 1069-66-5 API Hale Hana Maʻemaʻe Kiʻekiʻe